Laboratoire HRA Pharma - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Laboratoire HRA Pharma - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0)1300 321501 or Email: reportstore@bioportfolio.com 2
Laboratoire HRA Pharma - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Laboratoire HRA Pharma (HRA Pharma) is a pharmaceutical company that offers women s health and endocrinology products. The company offers wide range of women s health products such as emergency contraception, uterine fibroids, regular contraception, intimate health and genital herp products among others. Its portfolio of endocrinology products comprise advanced adrenal cortical carcinoma and cushing s syndrome medicines; and lysosafe service devices. The company offers partnerships with pharmaceutical companies, public and private institutions, healthcare professionals and service providers, and others. It has its operations in France, Germany, Ireland, Italy, Switzerland, Spain, Portugal, Belgium and the UK. HRA Pharma is headquartered in Paris, France. Laboratoire HRA Pharma - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma etrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of 3
the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Additional Details Publisher : Global Data Reference : GDPH132570D Number of Pages : 33 Report Format : PDF Publisher Information : 4
5
Table Of Contents for Laboratoire HRA Pharma - Pharmaceuticals & Healthcare - Deals and Alliances Profile Table of Contents Table of Contents 2List of Tables 3List of Figures 4Laboratoire HRA Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5Laboratoire HRA Pharma, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6Laboratoire HRA Pharma, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7Laboratoire HRA Pharma, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8Laboratoire HRA Pharma, Medical Devices Deals, 2010 to YTD 2016 10Laboratoire HRA Pharma, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11Laboratoire HRA Pharma, Pharmaceuticals & Healthcare, Deal Details 13Asset Purchase 13HRA Pharma Acquires Ovarian Cancer Immunotherapy from Pantarhei Bioscience 13Venture Financing 15Embera NeuroTherapeutics Raises USD1.9 Million in Series A-2 Financing 15Private Equity 16Astorg Asset Management and Goldman Sachs Acquire Laboratoire HRA Pharma 16Riverside Acquires Minority Stake in HRA Pharma 18Partnerships 19HRA Pharma Enters into Distribution Agreement with Laboratoires Carilene 19HRA Pharma Enters Into Co-Marketing Agreement With Chemo Iberica For Ulipristal 20Licensing Agreements 21Gedeon Richter Expands Licensing Agreement With HRA Pharma For Esmya 21Gedeon Richter Expands Licensing Agreement With HRA Pharma 22ASKA Pharma Enters Into Licensing Agreement With HRA Pharma For ellaone 23Shin Poong Pharma Enters Into Licensing Agreement With HRA Pharma For Ulipristal 24HRA Pharma Expands Licensing Agreement With Watson Pharma For Ulipristal 25PregLem Enters Into Licensing Agreement With HRA Pharma 26Watson Pharma Enters Into Licensing Agreement With HRA Pharma 27Asset Transactions 28Gedeon Richter Acquires Esmya from Laboratoire HRA Pharma 28Laboratoire HRA Pharma - Key Competitors 29Key Employees 30Locations And Subsidiaries 31Head Office 31Other Locations & Subsidiaries 31Appendix 33Methodology 33About GlobalData 33Contact Us 33Disclaimer 33 6
List Of Tables in Laboratoire HRA Pharma - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Tables Laboratoire HRA Pharma, Pharmaceuticals & Healthcare, Key Facts 1 Laboratoire HRA Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5 Laboratoire HRA Pharma, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6 Laboratoire HRA Pharma, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7 Laboratoire HRA Pharma, Deals By Therapy Area, 2010 to YTD 2016 8 Laboratoire HRA Pharma, Medical Devices Deals, 2010 to YTD 2016 10 Laboratoire HRA Pharma, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11 HRA Pharma Acquires Ovarian Cancer Immunotherapy from Pantarhei Bioscience 13 Embera NeuroTherapeutics Raises USD1.9 Million in Series A-2 Financing 15 Astorg Asset Management and Goldman Sachs Acquire Laboratoire HRA Pharma 16 Riverside Acquires Minority Stake in HRA Pharma 18 HRA Pharma Enters into Distribution Agreement with Laboratoires Carilene 19 HRA Pharma Enters Into Co-Marketing Agreement With Chemo Iberica For Ulipristal 20 Gedeon Richter Expands Licensing Agreement With HRA Pharma For Esmya 21 Gedeon Richter Expands Licensing Agreement With HRA Pharma 22 ASKA Pharma Enters Into Licensing Agreement With HRA Pharma For ellaone 23 Shin Poong Pharma Enters Into Licensing Agreement With HRA Pharma For Ulipristal 24 HRA Pharma Expands Licensing Agreement With Watson Pharma For Ulipristal 25 PregLem Enters Into Licensing Agreement With HRA Pharma 26 Watson Pharma Enters Into Licensing Agreement With HRA Pharma 27 Gedeon Richter Acquires Esmya from Laboratoire HRA Pharma 28 Laboratoire HRA Pharma, Key Competitors 29 Laboratoire HRA Pharma, Key Employees 30 Laboratoire HRA Pharma, Other Locations 31 Laboratoire HRA Pharma, Subsidiaries 31 7
List Of Figures, Charts and Diagrams in Laboratoire HRA Pharma - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Figures Laboratoire HRA Pharma, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1 Laboratoire HRA Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1 Laboratoire HRA Pharma, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1 Laboratoire HRA Pharma, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1 Laboratoire HRA Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5 Laboratoire HRA Pharma, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6 Laboratoire HRA Pharma, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7 Laboratoire HRA Pharma, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8 Laboratoire HRA Pharma, Medical Devices Deals, 2010 to YTD 2016 10 8
How to Buy... Laboratoire HRA Pharma - Pharmaceuticals & Healthcare - Deals and Alliances Profile Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and email it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0)1305 791844.We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Email: Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $250 Single User Price $500 Site License Price $750 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will email you the invoice with a payment link) Direct Wire Transfer (we will email you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0)1300 321501 We will be delighted to give you our personal attention. 9